









Markets
/
Stocks
/
nasdaq-brkr
/

Bruker Corp

BRKR

41.930USD

+0.890+2.17%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

6.35BMarket Cap

LossP/E TTM



Bruker Corp

41.930

+0.890+2.17%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Bruker Corp

Currency: USD Updated: 2026-02-06

Key Insights

Bruker Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 56 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 53.95.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bruker Corp's Score

Industry at a Glance

Industry Ranking

56 / 205

Overall Ranking

159 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Bruker Corp Highlights

StrengthsRisks

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 33.02% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 26.70%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 26.70%.

Undervalued

The company’s latest PE is -264.29, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 137.27M shares, increasing 0.08% quarter-over-quarter.

Held by ETHSX

Star Investor ETHSX holds 3.76K shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

53.954

Target Price

+31.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Bruker Corp is 6.80, ranking 128 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 860.50M, representing a year-over-year decrease of 0.45%, while its net profit experienced a year-over-year decrease of 252.57%.

Score

Industry at a Glance

Previous score

6.80

Change



Financials

5.47

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.20

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.78

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.15

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

5.40

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Bruker Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Bruker Corp is 6.80, ranking 147 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -264.29, which is -131.71% below the recent high of 83.82 and -29.88% above the recent low of -343.27.

Score

Industry at a Glance

Previous score

6.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 56/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Bruker Corp is 7.75, ranking 112 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 43.00, with a high of 75.00 and a low of 36.00.

Score

Industry at a Glance

Previous score

7.75

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

53.954

Target Price

+31.47%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Bruker Corp

BRKR

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Bruker Corp is 6.60, ranking 120 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 51.86 and the support level at 36.35, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.51

Change

0.09

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-1.919

Sell

RSI(14)

33.601

Neutral

STOCH(KDJ)(9,3,3)

8.873

Oversold

ATR(14)

2.139

Low Volatility

CCI(14)

-97.350

Neutral

Williams %R

90.461

Oversold

TRIX(12,20)

-0.507

Sell

StochRSI(14)

70.530

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

42.388

Sell

MA10

44.312

Sell

MA20

47.655

Sell

MA50

47.783

Sell

MA100

42.702

Sell

MA200

40.081

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Bruker Corp is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 94.12%, representing a quarter-over-quarter decrease of 0.35%. The largest institutional shareholder is The Vanguard, holding a total of 10.23M shares, representing 6.74% of shares outstanding, with 3.05% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Laukien (Frank H)

40.41M

+0.08%

Orbis Investment Management Ltd.

14.15M

+202.38%

Fidelity Management & Research Company LLC

11.42M

+52.90%

The Vanguard Group, Inc.

Star Investors

10.38M

-0.23%

Pallas Capital Advisors LLC

9.48M

-0.22%

BlackRock Institutional Trust Company, N.A.

9.22M

-1.91%

Laukien (Joerg C)

7.52M

T. Rowe Price Investment Management, Inc.

6.38M

-44.19%

State Street Investment Management (US)

3.74M

-1.18%

Edmond de Rothschild Asset Management (France) S.A.

3.17M

+110.32%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Bruker Corp is 7.43, ranking 41 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.19. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Bruker Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.